Resmed pulled one of its ventilators in September, and expects the discontinuation to weigh on growth through the rest of its ...
Stryker Q3 results missed the Street, with CEO Kevin Lobo citing a tough U.S. health insurance environment for hip and knee procedures.
CEO Mike Mahoney said the upcoming years will be a time of restructuring for Boston Scientific, following layoffs and ...
Onrad's radiology professional services will serve as RadNet's third reporting segment, joining imaging centers and digital ...
Available in Europe, the Liverty TIPS stent graft helps treat the veins feeding the liver by creating a new pathway for blood ...
Lambda Surgical will soon launch a first-in-human study of its new surgical guidance platform, the startup exclusively told ...
The Amplatzer Paraclose fills leaks around the edges of a replacement valve implant, without requiring the patient to undergo ...
Albert White stepped down as CEO, while former Steris chief Walter Rosebrough will run the business until a replacement is ...
Baxter boosted its financial forecast, in part from gains in its advanced surgery sales of hemostats, sealants and OR ...
Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...
Pharaoh Neuro's Neurapheresis system is being developed for the closed-loop filtering of CSF outside the body following a ...
Revenue climbed over 7% to $5.5 billion, surpassing analysts’ consensus of $5.35 billion. GE HealthCare shares rose over 7% on Wednesday morning following the report. “We delivered strong top-line ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results